Teva Pharmaceutical Industries Limited

TEVANYSEHealthcare● Active

$34.19

$-0.24(-0.70%)

Market Cap$39.8B

P/E Ratio—

52W High$37.35

52W Low$14.99

Avg Volume6.7M

Open$34.30

Beta0.85

Net Income Financials Revenue

Teva Pharmaceutical Industries Limited (TEVA) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

TEVA · net income · updated Jun 8, 2026

Core profitability metrics

TEVA · net income · margin · TTM · CAGR

Net income was $1.41B for FY2025 (fiscal year ending 2025-12-31), up 186.0% year-over-year. Net profit margin was 8.2%. Based on available data, Teva Pharmaceutical Industries Limited has been profitable since at least 2011.

FY2025 Net Income$1.41B▲ +186.0% YoY

Trailing 12M (TTM)$1.56Btrailing 4 quarters sum

Net Profit Margin8.2%$1.41B ÷ $17.26B

YoY Change+186.0%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · TEVA net income history · TEVA profit margin

Annual net income data

TEVA · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$1.41B▲ +186.0%8.2%$17.26B

FY2024Loss−$1.64B▼ 193.2%-9.9%$16.54B

FY2023Loss−$559.0M▲ +77.1%-3.5%$15.85B

FY2022Loss−$2.45B▼ 686.6%-16.4%$14.93B

FY2021$417.0M▲ +110.5%2.6%$15.88B

Net income vs peers (Healthcare)

TEVA vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Teva Pharmaceutical Industries LimitedYOU

TEVA

$1.41B+186.0%8.2%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Teva Pharmaceutical Industries Limited (TEVA) reported net income of $1.41B for FY2025 (fiscal year ending 2025-12-31), up 186.0% year-over-year. The net profit margin was 8.2% — meaning the company kept $0.08 of every dollar of revenue as profit.

Based on available data, Teva Pharmaceutical Industries Limited has been profitable since at least 2011. Net income reached a peak of $3.06B in FY2014. Data available for 15 fiscal years.

Teva Pharmaceutical Industries Limited's net profit margin was 8.2% for FY2025, based on the latest annual results.

Investors sometimes search for "Teva Pharmaceutical Industries Limited net worth" — the company's market capitalization is a separate figure from TEVA net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

TEVA net income · 5 questions

Teva Pharmaceutical Industries Limited is profitable. The company reported net income of $1.41B for FY2025, a net profit margin of 8.2%. Net income was up 186.0% year-over-year. Based on available data, Teva Pharmaceutical Industries Limited has been profitable since at least 2011.

is TEVA profitabledoes TEVA make a profitTEVA profitabilityTEVA profitable company

▸ Source: FMP /income-statement · GAAP · Teva Pharmaceutical Industries Limited · Teva Pharmaceutical Industries Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026